Journal of the American Academy of Dermatology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Biologic immunomodulatory medications and autoimmune cytopenias: A cross-sectional analysis of a national surveillance database
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 19, 2024 Category: Dermatology Authors: Lorin A. Bibb, Brian D. Adkins, Laura D. Stephens, Garrett S. Booth, Jeremy W. Jacobs Source Type: research
Response to Neale et al., “Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi”
To the Editor: We read the original article by Neale et al,1 reviewing the presence of magnetic resonance imaging (MRI) of the brain and spine abnormalities in children with congenital melanocytic nevi (CMNs) and their subsequent communication2 on “Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi” with inte rest. There has been significant discordance in the recommendations around the world regarding MRI screening in such scenarios. The authors recommended performing early craniospinal MRI screening in children who present with multiple CMNs among which at least 1 CMN has a p...
Source: Journal of the American Academy of Dermatology - March 18, 2024 Category: Dermatology Authors: Arunachalam Narayanan Tags: JAAD Online: Notes & comments Source Type: research
Response to Neale et al. ’s “Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi”
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 18, 2024 Category: Dermatology Authors: Arunachalam Narayanan Source Type: research
Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 18, 2024 Category: Dermatology Authors: Selina M. Yossef, Joseph C. English III Source Type: research
Cost and access considerations for magnetic resonance imaging screening of infants with congenital melanocytic nevi: Author's response to correspondence
To the Editor: In response to Dr Narayanan's letter addressing our original article,1 we are grateful for the opportunity to explore further considerations for magnetic resonance imaging (MRI) screening in children with congenital melanocytic nevi. This letter from India, along with prior letters in response to our study from authors in the United Kingdom and Germany, emphasize geographic variations in imaging practices. Such differences raise an additional variable for discussion: MRI screening must be decided in the context of cost and resource constraints. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Holly Neale, Isabella Plumptre, Leah Belazarian, Karen Wiss, Elena B. Hawryluk Tags: JAAD Online Source Type: research
Response to Desai et al, “Response to ‘Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study’”
To the Editor: We thank Desai et al1 for their thoughtful engagement with our article,2 in which we reported that treatment with low-dose oral minoxidil (LDOM) for androgenetic alopecia (AGA) was not associated with clinically significant systolic or diastolic blood pressure (BP) changes in either gender or in any age group. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Michael Ong, Shari R. Lipner Tags: JAAD Online Source Type: research
Cost and access considerations for MRI screening of infants with congenital melanocytic nevi: Author ’s response to correspondence
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Holly Neale, Isabella Plumptre, Leah Belazarian, Karen Wiss, Elena B. Hawryluk Source Type: research
Executive Summary: From the Medical Board of the National Psoriasis Foundation: Perioperative management of immunomodulatory agents in patients with psoriasis and psoriatic arthritis
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Warren A. James, Angela L. Rosenberg, Jashin J. Wu, Sylvia Hsu, April Armstrong, Elizabeth B. Wallace, Lara Wine Lee, Joseph Merola, Sergio Schwartzman, Dafna Gladman, Clive Liu, John Koo, Jason E. Hawkes, Soumya Reddy, Ron Prussick, Paul Yamauchi, Michae Source Type: research
Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study”
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Deesha Desai, Ambika Nohria, Michelle Sikora, Soutrik Mandal, Jerry Shapiro, Avrom S. Caplan, Michael Garshick, Kristen Lo Sicco Source Type: research
Low-dose oral minoxidil for treatment of androgenetic alopecia: gender differences in blood pressure and hypotension-related adverse effects
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 16, 2024 Category: Dermatology Authors: Michael Ong, Shari R. Lipner Source Type: research
Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
To the Editor: Patients with severe atopic dermatitis (AD), psoriasis (PSO), psoriatic arthritis (PsA), and inflammatory bowel disease (IBD) may present as a therapeutic challenge to clinicians. Rarely, patients may present with 2 of these systemic inflammatory diseases. For these patients, dual biologic therapy may offer a solution. Although dual biologic therapy is infrequently described, published reports describe promising results.1,2 Hesitation to prescribe dual therapy may exist due to concern of paradoxical upregulation of a separate axis after inhibition of intended axis, high costs, risk of infection, and lack ...
Source: Journal of the American Academy of Dermatology - March 15, 2024 Category: Dermatology Authors: Mary Grace Hren, Sophie Guenin, Saakshi Khattri Tags: Research letter Source Type: research
Herbal Transparency in Dermatology: Bridging Care in Hispanic Communities
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 15, 2024 Category: Dermatology Authors: Alexis Arza, Jules B. Lipoff Source Type: research
Successful use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 15, 2024 Category: Dermatology Authors: M. Grace Hren, Sophie Guenin, Saakshi Khattri Source Type: research
Differentiating generalized pustular psoriasis from acute generalized exanthematous pustulosis
To the Editor: Generalized pustular psoriasis (GPP) is a dermatologic emergency that is challenging to differentiate from other aseptic generalized pustular eruptions due to identical clinical and histopathologic findings, particularly those of acute generalized exanthematous pustulosis (AGEP).1,2 Although prognosis and treatment differ between the 2 diseases, no definitive features clearly distinguish GPP from AGEP. Therefore, we conducted a retrospective cohort study to compare the clinical and histopathologic features of GPP and AGEP in 2 geographic areas (United States and Japan) and developed a disease prediction scor...
Source: Journal of the American Academy of Dermatology - March 14, 2024 Category: Dermatology Authors: Mika Yamanaka-Takaichi, Miki Watanabe, Nneka I. Comfere, Olayemi Sokumbi, Christeebella O. Akpala, Austin Todd, Emily L. Branch, Aaron R. Mangold, Sho Hiroyasu, Daisuke Tsuruta, Afsaneh Alavi Tags: Research letter Source Type: research
Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study
Our findings align with the elevated cardiovascular risk observed for other immune-mediated inflammatory skin diseases, including psoriasis and atopic eczema. Our study adds understanding of the elevated cardiovascular risk among patients with autoimmune blistering disorders. Thus, recommendations on managing cardiovascular risk factors may be considered for these patients. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - March 14, 2024 Category: Dermatology Authors: Kasper Bonnesen, Christian F.B. Poulsen, Sigrun A.J. Schmidt, Henrik T. S ørensen, Morten Schmidt Source Type: research
